These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 34159427)

  • 21. Enteric polymers as acidifiers for the pH-independent sustained delivery of a weakly basic drug salt from coated pellets.
    Körber M; Ciper M; Hoffart V; Pearnchob N; Walther M; Macrae RJ; Bodmeier R
    Eur J Pharm Biopharm; 2011 Aug; 78(3):447-54. PubMed ID: 21443950
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Solid state interactions between the proton pump inhibitor omeprazole and various enteric coating polymers.
    Stroyer A; McGinity JW; Leopold CS
    J Pharm Sci; 2006 Jun; 95(6):1342-53. PubMed ID: 16625655
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Study of comparative bioavailability of omeprazole pellets.
    Karim S; Hay YK; Baie SH; Bukhari NI; Murtaza G
    Acta Pol Pharm; 2014; 71(3):463-8. PubMed ID: 25265826
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of a novel osmotically driven drug delivery system for weakly basic drugs.
    Guthmann C; Lipp R; Wagner T; Kranz H
    Eur J Pharm Biopharm; 2008 Jun; 69(2):667-74. PubMed ID: 18226884
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tableting and stability evaluation of enteric-coated omeprazole pellets.
    Türkoğlu M; Varol H; Celikok M
    Eur J Pharm Biopharm; 2004 Mar; 57(2):279-86. PubMed ID: 15018985
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diffusion of a freely water-soluble drug in aqueous enteric-coated pellets.
    Guo HX; Heinämäki J; Yliruusi J
    AAPS PharmSciTech; 2002; 3(2):E16. PubMed ID: 12916953
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bioavailability of omeprazole 20 mg capsules containing omeprazole 22.5% enteric coated pellets versus a reference product in healthy Bangladeshi male subjects: an open-label, single-dose, randomized-sequence, two-way crossover study.
    Islam MS; Trini AB; Shohag H; Ahmed MU; Maruf AA; Hasnat A
    Int J Clin Pharmacol Ther; 2011 Dec; 49(12):778-86. PubMed ID: 22122821
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of Ceolus™ microcrystalline cellulose grades for the direct compression of enteric-coated pellets.
    Kucera SU; DiNunzio JC; Kaneko N; McGinity JW
    Drug Dev Ind Pharm; 2012 Mar; 38(3):341-50. PubMed ID: 21870908
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulating the pH of bicarbonate solutions without purging gases: Application to dissolution testing of enteric coated tablets, pellets and microparticles.
    Scott N; Patel K; Sithole T; Xenofontos K; Mohylyuk V; Liu F
    Int J Pharm; 2020 Jul; 585():119562. PubMed ID: 32565282
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Review article: immediate-release proton-pump inhibitor therapy--potential advantages.
    Howden CW
    Aliment Pharmacol Ther; 2005 Dec; 22 Suppl 3():25-30. PubMed ID: 16303034
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Leaky enteric coating on ranitidine hydrochloride beads: dissolution and prediction of plasma data.
    Bendas ER; Ayres JW
    Eur J Pharm Biopharm; 2008 Aug; 69(3):977-85. PubMed ID: 18424095
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interaction of omeprazole with enteric-coated salicylate tablets.
    Nefesoglu FZ; Ayanoglu-Dülger G; Ulusoy NB; Imeryüz N
    Int J Clin Pharmacol Ther; 1998 Oct; 36(10):549-53. PubMed ID: 9799060
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The influence of gastric emptying kinetics on the drug release from enteric coated pellets in fasted state: an in vitro/in vivo correlation.
    Stefanič M; Locatelli I; Vrečer F; Sever T; Mrhar A; Bogataj M
    Eur J Pharm Biopharm; 2012 Oct; 82(2):376-82. PubMed ID: 22884655
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Eudragit L/HPMCAS blend enteric-coated lansoprazole pellets: enhanced drug stability and oral bioavailability.
    Fang Y; Wang G; Zhang R; Liu Z; Liu Z; Wu X; Cao D
    AAPS PharmSciTech; 2014 Jun; 15(3):513-21. PubMed ID: 24590548
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development of a bionic system for the simultaneous prediction of the release/absorption characteristics of enteric-coated formulations.
    Liu W; He X; Li Z; Gao X; Ma Y; Xun M; Liu C
    Pharm Res; 2013 Feb; 30(2):596-605. PubMed ID: 23135820
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Generic omeprazole delayed-release capsules: in vitro performance evaluations.
    Moore T; Smith A; Ye W; Toler DY; Westenberger BJ; Lionberger R; Raw A; Yu L; Buhse LF
    Drug Dev Ind Pharm; 2009 Aug; 35(8):917-21. PubMed ID: 19555236
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro evaluation of dissolution properties and degradation products of omeprazole in enteric-coated pellets.
    Storpirtis S; Rodrigues D
    Drug Dev Ind Pharm; 1998 Nov; 24(11):1101-7. PubMed ID: 9876567
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Omeprazole--a new formulation.
    Armstrong D
    Can J Gastroenterol; 1997; 11(8):655-6. PubMed ID: 9459043
    [No Abstract]   [Full Text] [Related]  

  • 39. Compaction of, and drug release from, coated drug pellets mixed with other pellets.
    Lundqvist AE; Podczeck F; Newton JM
    Eur J Pharm Biopharm; 1998 Nov; 46(3):369-79. PubMed ID: 9885311
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The influence of polymeric subcoats and pellet formulation on the release of chlorpheniramine maleate from enteric coated pellets.
    Bruce LD; Koleng JJ; McGinity JW
    Drug Dev Ind Pharm; 2003 Sep; 29(8):909-24. PubMed ID: 14570312
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.